March 2, 2026

Revvity, Inc. (RVTY) Stock Analysis: Unveiling a 21.62% Potential Upside in the Healthcare Sector

Revvity, Inc. (RVTY), a prominent player in the healthcare sector, operates within the diagnostics and research industry. Headquartered in Waltham, Massachusetts, Revvity offers a suite of health sciences solutions, technologies,..

argenx SE (ARGX) Stock Analysis: A Biotech Giant with 33% Upside Potential

argenx SE (NASDAQ: ARGX) has become a notable name in the biotechnology sector, capturing investor attention with its expansive pipeline and robust market presence. Based in the Netherlands, this commercial-stage..

Labcorp Holdings Inc. (LH) Stock Analysis: Strong Buy Ratings and Strategic Expansion Drive Investor Interest

Labcorp Holdings Inc. (NYSE: LH) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. The company stands out in its field, boasting a significant..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a Promising 79% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN), a leading player in the healthcare sector, is drawing significant attention from investors due to its robust growth prospects and a remarkable potential upside of..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Navigating Opportunities in the Medical Devices Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the healthcare sector, continues to capture attention with its diverse portfolio in the medical devices industry. Based in the United..

Illumina, Inc. (ILMN) Stock Analysis: Exploring the Upside with a 33% Return on Equity

Illumina, Inc. (NASDAQ: ILMN) continues to be a fascinating player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $20.56 billion, Illumina is..

Fidelity Special Values January update – shares rise on improving UK growth narrative

Fidelity Special Values PLC reported NAV and share price returns of 26.7% and 39.1% respectively over the 12 months to 31 January 2026, outperforming the FTSE All-Share Index...

Summit Therapeutics Inc. (SMMT) Stock Analysis: Biotech Innovator with an 89.92% Potential Upside

Investors have their eyes on Summit Therapeutics Inc. (NASDAQ: SMMT), a dynamic player in the biotechnology sector, as the company continues to make strides in developing groundbreaking therapies. With a..

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Contender with 20% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND) is making waves in the biotechnology sector, offering promising growth prospects for investors keen on healthcare innovations. The Danish-based biopharmaceutical company is renowned for its..

Biogen Inc. (BIIB) Stock Analysis: Evaluating the 7.22% Upside Potential Amidst Market Dynamics

Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector specializing in drug manufacturing, currently presents a noteworthy opportunity for investors, with its potential upside pegged at 7.22% based..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unlocking a 21.53% Potential Upside

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, has been making waves in the healthcare industry with its innovative approaches to drug delivery. With a market..

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: Robust Analyst Ratings Signal Potential 51.69% Upside

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a commercial-stage biopharmaceutical company headquartered in Boston, Massachusetts, is drawing significant attention from investors. Specializing in rare neuroendocrine diseases, Rhythm Pharmaceuticals has a market capitalization..

Vaxcyte, Inc. (PCVX)

⚠️ No article content returned.

..

Centene Corporation (CNC) Stock Analysis: Navigating Healthcare Growth Amidst Challenges

Investors eyeing Centene Corporation (NYSE: CNC) may find themselves intrigued by the company’s substantial market presence in the healthcare sector, yet wary of its current valuation metrics and performance indicators...

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Analyst Consensus and 12% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH), a key player in the healthcare sector, has drawn attention from investors with its strong portfolio of over-the-counter (OTC) health and personal care products...

Repligen Corporation (RGEN) Investor Outlook: Exploring a 44.7% Potential Upside in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN), a key player in the healthcare sector focusing on medical instruments and supplies, presents a captivating investment opportunity with a notable potential upside of 44.7%. With..

BioNTech SE (BNTX) Investor Outlook: Analyzing a 25.91% Potential Upside Amid Robust Pipeline

BioNTech SE (NASDAQ: BNTX) stands as a beacon in the biotechnology industry, particularly known for its contributions to immunotherapy for cancer and infectious diseases. The German-based company, with a market..

Masimo Corporation (MASI) Stock Analysis: Navigating Growth in the Medical Devices Sector

Masimo Corporation (NASDAQ: MASI) stands at the forefront of the healthcare industry with its innovative medical devices and patient monitoring technologies. Based in Irvine, California, Masimo has carved out a..

Corcept Therapeutics (CORT) Stock Analysis: Exploring an 83% Potential Upside in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT) has recently caught the attention of investors, with an impressive potential upside of 83.19% as indicated by analyst target prices. This biopharmaceutical company, based in..

Integer Holdings Corporation (ITGR) Stock Report: Evaluating Growth Potential in the Medical Devices Sector

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector, particularly within the medical devices industry, presents a compelling investment opportunity for those eyeing growth in the ever-evolving..

Search

Funds

March 2, 2026

Fidelity Special Values January update – shares rise on improving UK growth narrative

Fidelity Special Values PLC reported NAV and share price returns of 26.7% and 39.1% respectively over the 12 months to 31 January 2026, outperforming the FTSE All-Share Index...
Search

Funds

March 2, 2026

FTSE 100

Funds